Clinical Trial Update: Description of Relugolix Use in Patients With Prostate Cancer Within the VHA

View source ↗

Summary

Pfizer-sponsored clinical trial update describes the use of relugolix in patients with prostate cancer within the Veterans Health Administration. Results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Pfizer | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2025-12-11